Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women - Pilot Study

NCT02868905 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT02868905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02868905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women - Pilot Study
Lead sponsor
Central Hospital, Nancy, France
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2016
Completion date
September 30, 2018
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, obesity